Targeted radionuclide therapy is emerging as a new pillar in the treatment of prostate cancer and has been available to Slovenian patients since May of this year. In this type of treatment, radioactive drugs are used for targeted treatment of the diseased tissue, opening new and promising treatment options for a selected group of prostate cancer patients.
You can read more about it on the following website:
https://www.delo.si/delov-poslovni-center/zdravje/novi-obetavni-nacin-zdravljenja-raka-prostate
(Head of the Clinic for Nuclear Medicine at the University Medical Centre Ljubljana, Assoc. Prof. Dr. Katja Zaletel, and Dr. Daša Šfiligoj Planjšek, specialist in nuclear medicine. Photo: Jože Suhadolnik/Delo)